Do Escherichia coli strains causing acute cystitis have a distinct virulence repertoire?

Microbial Pathogenesis

Volumn 52, Issue 1, 2012, Pages 10-16

  Norinder, Birgit Stattin ^a,b   Köves, Béla ^a   Yadav, Manisha ^a   Brauner, Annelie ^b   Svanborg, Catharina ^a  

^a LUND UNIVERSITY   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Curli; Cystitis; Escherichia coli; P fimbriae; TcpC; Type 1 fimbriae

Indexed keywords

BACTERIAL PROTEIN; CELLULOSE; P FIMBRIAE; TCPC PROTEIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; ANTIINFECTIVE AGENT; ESCHERICHIA COLI PROTEIN;

ADULT; AGED; AMINO ACID SEQUENCE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CELL ORGANELLE; CURLI; CYSTITIS; ESCHERICHIA COLI; FEMALE; GENE SEQUENCE; HUMAN; IMMUNE RESPONSE; MAJOR CLINICAL STUDY; PAP GENE; PAPG GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PRSG GENE; SYMPTOM; URINARY TRACT INFECTION; ADOLESCENT; CLASSIFICATION; CLINICAL TRIAL; COMMUNICABLE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ESCHERICHIA COLI INFECTION; GENETICS; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI;

ADOLESCENT; ADULT; AGED; ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; CYSTITIS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; MIDDLE AGED; VIRULENCE FACTORS; YOUNG ADULT;

EID: 84859369590     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2011.08.005     Document Type: Article

References (46)

1. Orskov I., Orskov F., Birch-Andersen A., Kanamori M., Svanborg-Eden C. O, K, H and fimbrial antigens in Escherichia coli serotypes associated with pyelonephritis and cystitis. Scand J Infect Dis Suppl 1982, 33:18-25.
2. Johnson J.R. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991, 4:80-128.
3. Cirl C., Wieser A., Yadav M., Duerr S., Schubert S., Fischer H., et al. Subversion of Toll-like receptor signaling by a unique family of bacterial Toll/interleukin-1 receptor domain-containing proteins. Nat Med 2008, 14:399-406.
4. Sandberg T., Kaijser B., Lidin-Janson G., Lincoln K., Orskov F., Orskov I., et al. Virulence of Escherichia coli in relation to host factors in women with symptomatic urinary tract infection. J Clin Microbiol 1988, 26:1471-1476.
5. Johnson J.R., Russo T.A., Brown J.J., Stapleton A. papG alleles of Escherichia coli strains causing first-episode or recurrent acute cystitis in adult women. J Infect Dis 1998, 177:97-101.
6. Svanborg-Eden C., Hagberg L., Hull R., Hull S., Magnusson K.E., Ohman L. Bacterial virulence versus host resistance in the urinary tracts of mice. Infect Immun 1987, 55:1224-1232.
7. Mobley H.L., Chippendale G.R., Tenney J.H., Hull R.A., Warren J.W. Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract. J Clin Microbiol 1987, 25:2253-2257.
8. Hultgren S.J., Porter T.N., Schaeffer A.J., Duncan J.L. Role of type 1 pili and effects of phase variation on lower urinary tract infections produced by Escherichia coli. Infect Immun 1985, 50:370-377.
9. Schaeffer A.J., Schwan W.R., Hultgren S.J., Duncan J.L. Relationship of type 1 pilus expression in Escherichia coli to ascending urinary tract infections in mice. Infect Immun 1987, 55:373-380.
10. Wold A.E., Mestecky J., Tomana M., Kobata A., Ohbayashi H., Endo T., et al. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin. Infect Immun 1990, 58:3073-3077.
11. Malaviya R., Gao Z., Thankavel K., van der Merwe P.A., Abraham S.N. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. Proc Natl Acad Sci U S A 1999, 96:8110-8115.
12. Eto D.S., Jones T.A., Sundsbak J.L., Mulvey M.A. Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. PLoS Pathog 2007, 3:e100.
13. Pak J., Pu Y., Zhang Z.T., Hasty D.L., Wu X.R. Tamm-Horsfall protein binds to type 1 fimbriated Escherichia coli and prevents E. coli from binding to uroplakin Ia and Ib receptors. J Biol Chem 2001, 276:9924-9930.
14. Mulvey M.A., Lopez-Boado Y.S., Wilson C.L., Roth R., Parks W.C., Heuser J., et al. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 1998, 282:1494-1497.
15. Bergsten G., Wullt B., Schembri M.A., Leijonhufvud I., Svanborg C. Do type 1 fimbriae promote inflammation in the human urinary tract?. Cell Microbiol 2007, 9:1766-1781.
16. Smith Y.C., Rasmussen S.B., Grande K.K., Conran R.M., O'Brien A.D. Hemolysin of uropathogenic Escherichia coli evokes extensive shedding of the uroepithelium and hemorrhage in bladder tissue within the first 24 hours after intraurethral inoculation of mice. Infect Immun 2008, 76:2978-2990.
17. Bokranz W., Wang X., Tschape H., Romling U. Expression of cellulose and curli fimbriae by Escherichia coli isolated from the gastrointestinal tract. J Med Microbiol 2005, 54:1171-1182.
18. Svanborg C., Godaly G. Bacterial virulence in urinary tract infection. Infect Dis Clin North Am 1997, 11:513-529.
19. Plos K., Carter T., Hull S., Hull R., Svanborg Eden C. Frequency and organization of pap homologous DNA in relation to clinical origin of uropathogenic Escherichia coli. J Infect Dis 1990, 161:518-524.
20. Johnson J.R., Owens K., Gajewski A., Kuskowski M.A. Bacterial characteristics in relation to clinical source of Escherichia coli isolates from women with acute cystitis or pyelonephritis and uninfected women. J Clin Microbiol 2005, 43:6064-6072.
21. Marklund B.I., Tennent J.M., Garcia E., Hamers A., Baga M., Lindberg F., et al. Horizontal gene transfer of the Escherichia coli pap and prs pili operons as a mechanism for the development of tissue-specific adhesive properties. Mol Microbiol 1992, 6:2225-2242.
22. Johanson I.M., Plos K., Marklund B.I., Svanborg C. Pap, papG and prsG DNA sequences in Escherichia coli from the fecal flora and the urinary tract. Microb Pathog 1993, 15:121-129.
23. The Urinary Tract Infection Study Group Coordinated multicenter study of norfloxacin versus trimethoprim-sulfamethoxazole treatment of symptomatic urinary tract infections. J Infect Dis 1987, 155:170-177.
24. Lidin-Janson G., Hanson L.A., Kaijser B., Lincoln K., Lindberg U., Olling S., et al. Comparison of Escherichia coli from bacteriuric patients with those from feces of healthy schoolchildren. J Infect Dis 1977, 136:346-353.
25. Plos K., Connell H., Jodal U., Marklund B.I., Marild S., Wettergren B., et al. Intestinal carriage of P fimbriated Escherichia coli and the susceptibility to urinary tract infection in young children. J Infect Dis 1995, 171:625-631.
26. Tenke P., Bjerklund Johansen T.E., Matsumoto T., Tambyah P.A., Naber K.G. European and Asian guidelines on management and prevention of catheter-associated urinary tract infections. Urologiia 2008, 84-91.
27. Lund B., Marklund B.I., Stromberg N., Lindberg F., Karlsson K.A., Normark S. Uropathogenic Escherichia coli can express serologically identical pili of different receptor binding specificities. Mol Microbiol 1988, 2:255-263.
28. Otto G., Magnusson M., Svensson M., Braconier J., Svanborg C. pap genotype and P fimbrial expression in Escherichia coli causing bacteremic and nonbacteremic febrile urinary tract infection. Clin Infect Dis 2001, 32:1523-1531.
29. Dowling K.J., Roberts J.A., Kaack M.B. P-fimbriated Escherichia coli urinary tract infection: a clinical correlation. South Med J 1987, 80:1533-1536.
30. Connell I., Agace W., Klemm P., Schembri M., Marild S., Svanborg C. Type 1 fimbrial expression enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci U S A 1996, 93:9827-9832.
31. Gophna U., Barlev M., Seijffers R., Oelschlager T.A., Hacker J., Ron E.Z. Curli fibers mediate internalization of Escherichia coli by eukaryotic cells. Infect Immun 2001, 69:2659-2665.
32. Hagberg L., Jodal U., Korhonen T.K., Lidin-Janson G., Lindberg U., Svanborg Eden C. Adhesion, hemagglutination, and virulence of Escherichia coli causing urinary tract infections. Infect Immun 1981, 31:564-570.
33. Hedlund M., Frendeus B., Wachtler C., Hang L., Fischer H., Svanborg C. Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells. Mol Microbiol 2001, 39:542-552.
34. Song J., Duncan M.J., Li G., Chan C., Grady R., Stapleton A., et al. A novel TLR4-mediated signaling pathway leading to IL-6 responses in human bladder epithelial cells. PLoS Pathog 2007, 3:e60.
35. Klumpp D.J., Weiser A.C., Sengupta S., Forrestal S.G., Batler R.A., Schaeffer A.J. Uropathogenic Escherichia coli potentiates type 1 pilus-induced apoptosis by suppressing NF-kappaB. Infect Immun 2001, 69:6689-6695.
36. Mysorekar I.U., Hultgren S.J. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci U S A 2006, 103:14170-14175.
37. Schilling J.D., Lorenz R.G., Hultgren S.J. Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect Immun 2002, 70:7042-7049.
38. Thumbikat P., Berry R.E., Schaeffer A.J., Klumpp D.J. Differentiation-induced uroplakin III expression promotes urothelial cell death in response to uropathogenic E. coli. Microbes Infect 2009, 11:57-65.
39. Holden N.J., Totsika M., Mahler E., Roe A.J., Catherwood K., Lindner K., et al. Demonstration of regulatory cross-talk between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. Microbiology 2006, 152:1143-1153.
40. Hagberg L., Hull R., Hull S., Falkow S., Freter R., Svanborg Eden C. Contribution of adhesion to bacterial persistence in the mouse urinary tract. Infect Immun 1983, 40:265-272.
41. Bergsten G., Wullt B., Svanborg C. Escherichia coli, fimbriae, bacterial persistence and host response induction in the human urinary tract. Int J Med Microbiol 2005, 295:487-502.
42. Ragnarsdottir B., Jonsson K., Urbano A., Gronberg-Hernandez J., Lutay N., Tammi M., et al. Toll-like receptor 4 promoter polymorphisms: common TLR4 variants may protect against severe urinary tract infection. PLoS One 2010, 5:e10734.
43. Fischer H., Lutay N., Ragnarsdottir B., Yadav M., Jonsson K., Urbano A., et al. Pathogen specific, IRF3-dependent signaling and innate resistance to human kidney infection. PLoS Pathog 2010, 6.
44. Hughes L.B., Criswell L.A., Beasley T.M., Edberg J.C., Kimberly R.P., Moreland L.W., et al. Genetic risk factors for infection in patients with early rheumatoid arthritis. Genes Immun 2004, 5:641-647.
45. Hawn T.R., Scholes D., Li S.S., Wang H., Yang Y., Roberts P.L., et al. Toll-like receptor polymorphisms and susceptibility to urinary tract infections in adult women. PLoS One 2009, 4:e5990.
46. Frendeus B., Godaly G., Hang L., Karpman D., Lundstedt A.C., Svanborg C. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 2000, 192:881-890.